Vaccinex, Inc., a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease (AD) through the inhibition of Semaphorin 4D (SEMA4D), today announced that ...
Spread the love“`html In an increasingly digital world, capturing and organizing your handwritten notes, receipts, and documents is more important than ever. Whether you’re a student, a professional, ...